Sinotherapeutics Inc. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 213.36 million compared to CNY 186.9 million a year ago. Revenue was CNY 213.36 million compared to CNY 186.9 million a year ago.

Net income was CNY 44.07 million compared to CNY 67.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.16 a year ago. Diluted earnings per share from continuing operations was CNY 0.1 compared to CNY 0.16 a year ago.